{"disease":{"id":"dengue-disease","name":"dengue disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06268691","title":"Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating","phase":"NA","overall_status":"COMPLETED","enrollment_count":35000,"lead_sponsor_name":"Rocio Cardenas Sanchez","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT07543458","title":"Therapeutics for Moderate and Severe Dengue","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":8800,"lead_sponsor_name":"Oxford University Clinical Research Unit, Vietnam","has_results":false},{"nct_id":"NCT05218304","title":"Baromètre Santé Adulte 2021-2022","phase":"NA","overall_status":"SUSPENDED","enrollment_count":5471,"lead_sponsor_name":"Agence Sanitaire et Sociale de Nouvelle Calédonie","has_results":false},{"nct_id":"NCT05507450","title":"Safety and Immunogenicity of Three V181 Dengue Vaccine Potencies in Adults (V181-003)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1271,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT07517731","title":"Using Digital Technology for the Prevention of Aedes-Borne Diseases in Colombian Communities","phase":"NA","overall_status":"COMPLETED","enrollment_count":900,"lead_sponsor_name":"University of Freiburg","has_results":false},{"nct_id":"NCT06599970","title":"Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility","phase":"","overall_status":"RECRUITING","enrollment_count":810,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false},{"nct_id":"NCT02993757","title":"Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":528,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02979535","title":"Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":480,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT04434846","title":"Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT00788151","title":"Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT07000747","title":"Molecular and Cellular Basis of Severe Forms of Dengue in Sickle Cell Patients","phase":"","overall_status":"RECRUITING","enrollment_count":130,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Guadeloupe","has_results":false},{"nct_id":"NCT07409857","title":"International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR)","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Mahidol University","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}